Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are
chronic, progressive, immune-mediated diseases of adults and children that have no cure …

Helicobacter pylori (H. pylori) is a gram-negative bacterium that infects approximately 4.4
billion individuals worldwide. However, its prevalence varies among different geographic …

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) has become an epidemic largely
due to the worldwide increase in obesity. While lifestyle modifications and …

Background Non‐alcoholic fatty liver disease (NAFLD) is found in inflammatory bowel
disease (IBD). However, uncertainties remain on the magnitude of the association. Aims To …

Background Nonalcoholic fatty liver disease (NAFLD) is a significant public health burden,
with up to 30% of the US population affected. The prevalence of NAFLD among …

Background Nonalcoholic fatty liver disease (NAFLD) is common in inflammatory bowel
diseases (IBD). Herein, NAFLD prevalence and risk factors in a large IBD cohort were …

Emerging data have highlighted the co-existence of non-alcoholic fatty liver disease
(NAFLD) and inflammatory bowel disease; both of which are increasingly prevalent …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) is a frequently reported condition
in patients with inflammatory bowel disease (IBD). Both intestinal inflammation and …

Inflammatory bowel diseases are associated with various hepatobiliary disorders, reported
both in Crohn's disease and ulcerative colitis. They may occur at any moment in the natural …

Background Inflammatory bowel disease (IBD) patients may be at risk for nonalcoholic fatty
liver disease (NAFLD) due to chronic inflammation, hepatotoxic drugs, and alteration of the …